Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycogenin 2 pseudogene 2 (GYG2P2, ENSG00000271580) is a pseudogene annotated in the human genome and does not encode a functional protein or have a direct biological activity. It is a non-coding genomic fragment, likely a relic of a duplication or processing event related to the functional glycogenin-2 (GYG2) gene, which itself is a protein-coding gene involved in glycogen biosynthesis in the liver[3][8][9]. Pseudogenes such as GYG2P2 do not act as enzymes, receptors, or therapeutic targets, and generally have no direct disease, drug, or biomarker roles[3][11]. In rare cases, pseudogenes can exert regulatory effects or contribute to genomic instability, but there is no evidence for such activity from GYG2P2[3][11].\n\nIf you require information about the functional glycogenin-2 (GYG2), it is a self-glucosylating enzyme important in glycogen biosynthesis, but this is distinct from the pseudogene[2][8][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycogenin 2 pseudogene 2 (GYG2P2).